Wealth Enhancement Advisory Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.15M Buy
16,842
+2,663
+19% +$523K 0.01% 1287
2026
Q1
$2.51M Sell
14,179
-3,060
-18% -$595K 0.01% 1268
2025
Q4
$3.12M Buy
17,239
+2,152
+14% +$392K ﹤0.01% 1262
2025
Q3
$2.74M Buy
15,087
+1,508
+11% +$268K ﹤0.01% 1267
2025
Q2
$2.4M Sell
13,579
-17,246
-56% -$3M ﹤0.01% 1263
2025
Q1
$5.22M Buy
30,825
+3,210
+12% +$527K 0.01% 821
2024
Q4
$4.17M Buy
27,615
+16,958
+159% +$2.64M 0.01% 867
2024
Q3
$1.65M Buy
10,657
+1,346
+14% +$201K ﹤0.01% 1148
2024
Q2
$1.27M Sell
9,311
-246
-3% -$33.7K ﹤0.01% 1166
2024
Q1
$1.27M Sell
9,557
-8,267
-46% -$1.07M ﹤0.01% 1128
2023
Q4
$2.46M Buy
17,824
+8,820
+98% +$1.16M 0.01% 839
2023
Q3
$1.1M Buy
+9,004
New +$1.2M ﹤0.01% 1057
2023
Q1
Sell
-3,526
Closed -$514K 530
2022
Q4
$514K Buy
+3,526
New +$507K 0.01% 272

Other funds holding DGX

Wealth Enhancement Advisory Services's DGX Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Quest Diagnostics (DGX) stake by 19% in Q2 2026, buying an estimated $523K and bringing the position to 16,842 shares worth $3.15M. The position accounts for 0.01% of the portfolio, ranked #1287.

Wealth Enhancement Advisory Services first reported a position in DGX in Q4 2022 and has held it in 13 quarters since. The position peaked at $5.22M in Q1 2025. 264 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Wealth Enhancement Advisory Services held 16,842 shares of Quest Diagnostics worth $3.15M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 2,663 Quest Diagnostics shares in Q2 2026, an estimated $523K.
  • Quest Diagnostics made up 0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #1287 holding.
  • Wealth Enhancement Advisory Services first reported a position in Quest Diagnostics in Q4 2022 and has held it in 13 quarters since.
  • Wealth Enhancement Advisory Services's Quest Diagnostics position peaked at $5.22M in Q1 2025.
  • 264 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.